PhageLab

Private

SantiagoHealthcare & Life Scienceshttp://phagelab.com/

Last Round

VC Round

Apr 10, 2026

Total Funding Raised

$44.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

PhageLab is a biotechnology company that develops tailor-made antibacterial solutions based on bacteriophages for the livestock and poultry industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

bacteriophage technologyphage therapyantibiotic alternativeslivestock healthAI drug discoveryagritechantimicrobial resistanceAMRbacteriophage cocktailsfood safetyprecision animal healthpathogen controlanimal diagnosticspoultry healthcattle healthzootechnical additives

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PhageLab Comparables

Compare PhageLab with similar companies based on industry and business-model similarity.

PhageLab comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

PhageLab Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Apr 10, 2026
Convertible Debt	Dec 11, 2025
Series A	Jan 23, 2024
Series A	Oct 5, 2021

View all Funding Rounds

PhageLab Investors

Notable investors and investment history

PhageLab investors
Investor	Rounds
Nazca	Series A
Humboldt Fund	Series A
Collaborative Fund	Series A
Waterlemon	Series A
The Yield Lab	Convertible Debt
Kaszek	Series A, Convertible Debt, VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Dec 11, 2025
$4M round led by Kaszek

View all signals

PhageLab Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

PhageLab Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PhageLab's valuation, stock price, and market status.

Firmographic Details

HeadquartersSantiago

Year Founded2009

Last FundingApr 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.